Controlled sleep
BehavioralDuration and timing of sleep will be assigned and monitored in a controlled laboratory environment with controlled lighting and meals.
NCT Number: NCT04211506
This study is designed to assess neurobehavioral performance, as well as genetic and other physiological changes associated with variations in timing and quantity of sleep.
Looking for future studies?
Notify Me20 year–45 year
All sexes
Interventional
Not applicable
Brigham and Women's Hospital, Boston, Massachusetts, United States
During a 1.5 week inpatient laboratory protocol, subjects will undergo one of four parallel sleep conditions. Subjects will be randomly assigned to each condition group. During their time in the laboratory, biological samples (e.g., blood) will be collected for genetic and other analyses, and sleep quantity and quality will be monitored. Additionally responses on neurobehavioral tests and surveys will be monitored for differences among the groups.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Duration and timing of sleep will be assigned and monitored in a controlled laboratory environment with controlled lighting and meals.
Time frame: Samples for gene expression will be collected at frequent intervals over 10 days in a sleep laboratory. Subjects will be in a time-free environment, and not told sampling frequency.
Levels of expression of all genes may be compared across time and among study arms with different sleep patterns using RNA-Seq and differential expression analysis with generalized linear models. Patterns may be sought with and potential relevance to sleep, circadian rhythms, and/or neurobehavioral performance.
Time frame: Neurobehavioral assays may be conducted at frequent intervals over 10 days in a sleep laboratory. Subjects will be in a time-free environment, and not told assay frequency.
Neurobehavioral performance may be compared across time and among study arms with different sleep patterns. Specifically, differences will be examined in subjective and objective neurobehavioral assays (Karolinska sleepiness scale, Performance effort and evaluation rating scale, Digit symbol substitution test, Stroop performance, Raven matrix task, Comparative visual search, Face-name task, Psychomotor vigilance test, Visual analog scale, Track test, and the Balloon analog risk task). Patterns may be sought with relevance to sleep, circadian rhythms, and/or other outcome measures.
Time frame: Approximately two oral samples may be taken for DNA analyses during the 10 days in a sleep laboratory.
Analysis of genetic variants may be used to assess inherited genetic differences among subjects and potential relevance to sleep, circadian rhythms, and/or neurobehavioral performance.
Time frame: Approximately three fecal samples will be collected over the 10 days in a sleep laboratory for potential future microbiome analyses.
Fecal samples will be collected and may be analyzed in the future for microbiome differences among subjects, over time, and/or with respect to study conditions and metrics (e.g., differences in microbiome associated with sleep and/or neurobehavioral performance).
Time frame: A series of blood samples will be collected over the 10 days in a sleep laboratory for potential future analyses.
Blood samples will be collected and may be analysed in the future for metabolite, protein, or other molecular differences among subjects, over time, and/or with respect to study conditions and metrics (e.g., differences associated with sleep and/or neurobehavioral performance).
Time frame: Saliva and urine samples will be collected frequently during wake over the 10 days in a sleep laboratory for potential future analyses
Urine and saliva samples will be collected and may be analyzed in the future for metabolite, protein, or other genetic differences among subjects, over time, and/or with respect to study conditions and metrics
Time frame: Frequent data collection will be made prior to and during the 10 days in a sleep laboratory, including approximately 3 nights of polysomnography.
Actigraphy, polysomnography, screening data and log/diary information will be collected and may be analysed in the future for comparison with other outcome measures, and particularly associations with sleep, circadian rhythms, and/or neurobehavioral performance.
Civil Aerospace Medical Institute
Fed
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05309473
Acoustic Stimulation, Alertness
Silver Spring, Maryland, United States
View Trial DetailsNCT07495592
Cognitive, Dyssomnias
Tampa, Florida, United States
View Trial DetailsNCT05381532
Dyssomnias, Mental Disorders
Boston, Massachusetts, United States
View Trial DetailsNCT03747367
Chronobiology Disorders, Circadian Dysregulation
Boulder, Colorado, United States
View Trial Details